Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AAV9-DOK7 gene therapy reduces disease severity in Smn SMA model mice
Kevin A. Kaifer, Eric Villalón, C E Smith, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 530, Iss. 1, pp. 107-114
Open Access | Times Cited: 22

Showing 22 citing articles:

Spinal Muscular Atrophy: In the Challenge Lies a Solution
Brunhilde Wirth
Trends in Neurosciences (2021) Vol. 44, Iss. 4, pp. 306-322
Closed Access | Times Cited: 136
Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine
Helena Chaytow, Kiterie M. E. Faller, Yu-Ting Huang, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100346-100346
Open Access | Times Cited: 116
Innate Immune Response to Viral Vectors in Gene Therapy
Yixuan Wang, Wenwei Shao
Viruses (2023) Vol. 15, Iss. 9, pp. 1801-1801
Open Access | Times Cited: 17
Recent insights into neuromuscular junction biology in Duchenne muscular dystrophy: Impacts, challenges, and opportunities
Sean Y. Ng, Vladimir Ljubicic
EBioMedicine (2020) Vol. 61, pp. 103032-103032
Open Access | Times Cited: 33
SMN controls neuromuscular junction integrity through U7 snRNP
Sarah Tisdale, Meaghan Van Alstyne, Christian M. Simon, et al.
Cell Reports (2022) Vol. 40, Iss. 12, pp. 111393-111393
Open Access | Times Cited: 21
Targeting neuromuscular junction to treat neuromuscular disorders
Rizwan Qaisar
Life Sciences (2023) Vol. 333, pp. 122186-122186
Closed Access | Times Cited: 11
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
Genes (2024) Vol. 15, Iss. 8, pp. 999-999
Open Access | Times Cited: 4
An Overview of the Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy
Yueyi Li, Hongyu Zeng, Yuhao Wei, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 5-6, pp. 180-191
Closed Access | Times Cited: 10
Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
Yu‐Fu Wu, Jun‐An Chen, Yuh‐Jyh Jong
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity
Gangadhar P Vadla, Sara M. Ricardez Hernandez, Jiude Mao, et al.
JCI Insight (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 15
Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA)
Zhihua Feng, Steven Lam, Elena-Marie Sandino Tenn, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8015-8015
Open Access | Times Cited: 18
Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK
Jamie Lim, Roy Augustinus, Jaap J. Plomp, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases
W. Chiu, Ya-Hsin Hsun, Kao-Jung Chang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9589-9589
Open Access | Times Cited: 14
Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives
Ana Fajardo‐Serrano, Alberto J. Rico, Elvira Roda, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 746-746
Open Access | Times Cited: 8
DOK7 Promotes NMJ Regeneration After Nerve Injury
Ethan D. Kosco, Hongyang Jing, Peng Chen, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1453-1464
Closed Access | Times Cited: 7
Building, Breaking, and Repairing Neuromuscular Synapses
Ruth Herbst, Maartje G. Huijbers, Julien Oury, et al.
Cold Spring Harbor Perspectives in Biology (2024) Vol. 16, Iss. 5, pp. a041490-a041490
Closed Access | Times Cited: 1
Systematic review and meta-analysis determining the benefits of in vivo genetic therapy in spinal muscular atrophy rodent models
Ellie Chilcott, Evalyne W. Muiruri, Theodore C. Hirst, et al.
Gene Therapy (2021) Vol. 29, Iss. 9, pp. 498-512
Open Access | Times Cited: 8
Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7
Yuting Huang, Hannah R. Crick, Helena Chaytow, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 617-628
Open Access | Times Cited: 3
A link between agrin signalling and Cav3.2 at the neuromuscular junction in spinal muscular atrophy
Perrine Delers, Delphine Sapaly, Badih Salman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
Judith Cossins, Imre Kozma, Claudia Canzonetta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
Judith Cossins, Imre Kozma, Claudia Canzonetta, et al.
Brain Communications (2024) Vol. 7, Iss. 1
Open Access
SMN controls neuromuscular junction integrity through U7 snRNP
Sarah Tisdale, Meaghan Van Alstyne, Christian M. Simon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Page 1

Scroll to top